New Product Launches To Aid Boston Scientific ’s Q1

Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates. A rise in elective surgeries performed and market share gains for some of its products will likely aid the…#bostonscientific #bsx #bostonscientifics #xl #baylis #acotec #q4 #eps #peercomparisons #merck

Source: Reuters: Health - April 25, 2023 Category: Consumer Health News Source Type: news